middle.news
LTR Pharma Hits 1,000 SPONTAN Prescriptions, Eyes US Launch in H1 2026
8:38am on Wednesday 28th of January, 2026 AEDT
•
Healthcare
Read Story
LTR Pharma Hits 1,000 SPONTAN Prescriptions, Eyes US Launch in H1 2026
8:38am on Wednesday 28th of January, 2026 AEDT
Key Points
SPONTAN surpasses 1,000 prescriptions via TGA Special Access Scheme
Phase II pharmacokinetic study underway with initial data due Q2 2026
ROXUS development on track for US launch in first half of 2026
Strategic investment increases stake in omega-3 producer LevOmega to 43%
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
LTR PHARMA (ASX:LTP)
OPEN ARTICLE